Fabry Disease in 21 Major Markets – 2018-2028 – ResearchAndMarkets.com

The “Epiomic
Epidemiology Series: Fabry Disease Forecast In 21 Major Markets
2018-2028” report has been added to ResearchAndMarkets.com’s
offering.

This report provides the current prevalent population for Fabry Disease
across 21 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK,
Poland, Netherlands, Austria, Portugal, Russia, Turkey, Japan, China,
South Korea, India, Australia, Brazil, Mexico, Argentina) split by
gender and 5-year age cohort. Along with the current prevalence, the
report also contains a disease overview of the risk factors, disease
diagnosis and prognosis along with specific variations by geography and
ethnicity.

Providing a value-added level of insight from the analysis team, several
of the main symptoms and co-morbidities of Fabry disease have been
quantified and presented alongside the overall prevalence figures. These
sub-populations within the main disease are also included at a country
level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Fabry disease include:

Reasons to buy

Key Topics Covered:

For more information about this report visit https://www.researchandmarkets.com/research/6xg6r7/fabry_disease_in?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005621/en/

Leave a Comment